{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:50:52Z","timestamp":1794293452326,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R278-2018-804"],"award-info":[{"award-number":["R278-2018-804"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.atherosclerosis.2023.117218","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T02:05:41Z","timestamp":1691546741000},"page":"117218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["APOE and vascular disease: Sequencing and genotyping in general population cohorts"],"prefix":"10.1016","volume":"385","author":[{"given":"Katrine L.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-5027","authenticated-orcid":false,"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.atherosclerosis.2023.117218_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.117218_bib2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9943","key":"10.1016\/j.atherosclerosis.2023.117218_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117218_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.atherosclerosis.2023.117218_bib5","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2023.117218_bib6","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib7","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2835","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"issue":"33","key":"10.1016\/j.atherosclerosis.2023.117218_bib8","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","article-title":"Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort","volume":"40","author":"Rasmussen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117218_bib9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117218_bib10","first-page":"268","article-title":"Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation","volume":"37","author":"Sing","year":"1985","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117218_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01790099","article-title":"Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels","volume":"80","author":"Smit","year":"1988","journal-title":"Hum. Genet."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117218_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117218_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117218_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117218_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117218_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOL.0000000000000291","article-title":"Relation between plasma and brain lipids","volume":"27","author":"Wellington","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"7399","key":"10.1016\/j.atherosclerosis.2023.117218_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"issue":"6075","key":"10.1016\/j.atherosclerosis.2023.117218_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2016.10.037","article-title":"Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review","volume":"255","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5123","key":"10.1016\/j.atherosclerosis.2023.117218_bib20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"35","key":"10.1016\/j.atherosclerosis.2023.117218_bib21","doi-asserted-by":"crossref","first-page":"E1033","DOI":"10.1503\/cmaj.180066","article-title":"Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study","volume":"190","author":"Rasmussen","year":"2018","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117218_bib22","first-page":"21679","article-title":"Correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia in Alzheimer's disease and vascular dementia","volume":"8","author":"Mou","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117218_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000095246","article-title":"Apolipoprotein E epsilon4 allele is associated with vascular dementia","volume":"22","author":"Baum","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117218_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000285166","article-title":"Association between APOE epsilon4 allele and vascular dementia: the Cache County study","volume":"29","author":"Chuang","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117218_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00702-011-0714-6","article-title":"ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis","volume":"119","author":"Liu","year":"2012","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117218_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2012.02.031","article-title":"Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis","volume":"514","author":"Yin","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117218_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ije\/dyt034","article-title":"Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals","volume":"42","author":"Khan","year":"2013","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117218_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.STR.0000199065.12908.62","article-title":"Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls","volume":"37","author":"Sudlow","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-511X-13-47","article-title":"Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies","volume":"13","author":"Zhang","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2023.117218_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000442678","article-title":"ApoE polymorphisms and the risk of different subtypes of stroke in the Chinese population: a comprehensive meta-analysis","volume":"41","author":"Chen","year":"2016","journal-title":"Cerebrovasc. Dis."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117218_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117218_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"In Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2023.117218_bib33","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117218_bib34","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","article-title":"Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease","volume":"11","author":"Nordestgaard","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117218_bib35","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/alz.12165","article-title":"APOE and dementia - resequencing and genotyping in 105,597 individuals","volume":"16","author":"Rasmussen","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","article-title":"Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population","volume":"246","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117218_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"9326","key":"10.1016\/j.atherosclerosis.2023.117218_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"9753","key":"10.1016\/j.atherosclerosis.2023.117218_bib39","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2023.117218_bib40","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jacc.2019.03.517","article-title":"Low LDL cholesterol by PCSK9 variation reduces cardiovascular mortality","volume":"73","author":"Benn","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2021.05.007","article-title":"APOE gene variants in primary dyslipidemia","volume":"328","author":"Khalil","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"EBioMedicine"},{"issue":"6012","key":"10.1016\/j.atherosclerosis.2023.117218_bib43","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2023.117218_bib44","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117218_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117218_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2023.117218_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure-function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv. Protein Chem."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117218_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9874","key":"10.1016\/j.atherosclerosis.2023.117218_bib49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023051341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023051341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:54:02Z","timestamp":1758156842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023051341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"alternative-id":["S0021915023051341"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117218","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE and vascular disease: Sequencing and genotyping in general population cohorts","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117218"}}